GENEVA, May 15 -- JANUX THERAPEUTICS, INC. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130) filed a patent application (PCT/US2024/054248) for "ANTIBODIES FOR TARGETING PSMA AND CD28 AND USES THEREOF" on Nov 01, 2024. With publication no. WO/2025/097043, the details related to the patent application was published on May 08, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CAMPBELL, David (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130), DIRAIMONDO, Thomas R. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130)
Abstract:
Disclosed here...